日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Downregulated of CTGF reveals mechanism, remodels immune microenvironment, modulates drug sensitivity in bladder cancer

CTGF表达下调揭示其作用机制,重塑免疫微环境,并调节膀胱癌的药物敏感性

Zhang, Hanjie; Tang, Kaiqiang; Chen, Yiyang; Chen, Guoqiang; Tan, Geli; Dong, Yiyu; Ling, Jingwen; He, Rongquan; Qin, Diyuan; He, Juan; Li, Shenghua; Dang, Yiwu; Chen, Gang; Feng, Zhenbo; Deng, Lili

Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.

靶向 Hurthle 细胞癌中的 mTOR 通路可产生强大的抗肿瘤活性

Dong Yiyu, Gong Yongxing, Kuo Fengshen, Makarov Vladimir, Reznik Ed, Nanjangud Gouri J, Aras Omer, Zhao Huiyong, Qu Rui, Fagin James A, Sherman Eric J, Xu Bin, Ghossein Ronald, Chan Timothy A, Ganly Ian

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection

对来自两个主要资源的肾癌细胞系进行分析,可以实现基因组指导的细胞系选择。

Sinha, Rileen; Winer, Andrew G; Chevinsky, Michael; Jakubowski, Christopher; Chen, Ying-Bei; Dong, Yiyu; Tickoo, Satish K; Reuter, Victor E; Russo, Paul; Coleman, Jonathan A; Sander, Chris; Hsieh, James J; Hakimi, A Ari

Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

人类透明细胞肾细胞癌的肿瘤异种移植,但相应的细胞系不能重现舒尼替尼的临床反应:使用活检样本的可行性

Dong Yiyu, Manley Brandon J, Becerra Maria F, Redzematovic Almedina, Casuscelli Jozefina, Tennenbaum Daniel M, Reznik Ed, Han Song, Benfante Nicole, Chen Ying-Bei, Arcila Maria E, Aras Omer, Voss Martin H, Feldman Darren R, Motzer Robert J, Fabbri Nicola, Healey John H, Boland Patrick J, Chawla Mohit, Durack Jeremy C, Lee Chung-Han, Coleman Jonathan A, Russo Paul, Hakimi A Ari, Cheng Emily H, Hsieh James J